Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Bacterial Flora of the Large Intestine

Bacterial Flora of the Large Intestine

The gut microbiome is formed by a vast and diverse community of bacteria that colonizes our large intestine. These bacteria start residing in the gut from birth and continue diversifying throughout life, influenced by factors such as diet, lifestyle, and stress. The gut bacterial community also includes bacteria from food and those that enter the colon through the anus.
The normal gut flora of the colon plays a critical role in generating essential vitamins such as vitamins K, B5, and B7.

Inflammatory Bowel Disease III: Crohn's Disease

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...

Dysbiosis of the Gut Microbiota

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...

Inflammatory Bowel Disease II: Ulcerative Colitis

Inflammatory Bowel Disease II: Ulcerative Colitis

Ulcerative colitis is a chronic inflammatory disorder of the colon characterized by continuous mucosal inflammation that typically begins in the rectum and extends proximally in a uniform pattern. Its pathogenesis involves a complex interplay of genetic predisposition, immune dysregulation, and environmental influences. These factors converge to impair the colon’s epithelial defenses and promote an exaggerated inflammatory response against luminal contents.Breakdown of the Mucosal BarrierA...

Microbiota of the Stomach and Small Intestine

Microbiota of the Stomach and Small Intestine

The human gastrointestinal (GI) tract is characterized by distinct physicochemical conditions that shape its microbial communities. Among these, the stomach presents a particularly challenging environment for microbial colonization due to its highly acidic pH, ranging from 1 to 3. This extreme acidity effectively limits microbial density. However, certain acid-tolerant microorganisms are capable of surviving in this niche. Notably, Helicobacter pylori can colonize the gastric mucosa,...

Inflammatory Bowel Disease I: Introduction

Inflammatory Bowel Disease I: Introduction

Inflammatory bowel disease is a group of chronic disorders marked by recurrent inflammation of the gastrointestinal tract due to an abnormal immune response against gut microflora. This leads to tissue damage. The two main forms are Crohn’s disease and ulcerative colitis.Crohn’s DiseaseCrohn’s disease is a relapsing inflammatory disorder that can affect any part of the GI tract, from the mouth to the anus. It involves all layers of the bowel wall (transmural) and shows “skip lesions” in which...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

The triple association of sickle cell disease, primary sclerosing cholangitis and inflammatory bowel disease (SCD-PSC-IBD): iceberg in sight.

Clinics and research in hepatology and gastroenterology·2025

Same author

Effectiveness of medical treatments depending on Crohn's disease location. That is the question.

Clinics and research in hepatology and gastroenterology·2025

Same author

Impact of Histological Remission for Predicting Clinical Relapse in Crohn's Disease: A Post Hoc Analysis of the Prospective STORI Cohort.

Journal of Crohn's & colitis·2024

Same author

Risk of SARS-CoV-2 infection in healthcare workers with inflammatory bowel disease: a case-control study.

Infection prevention in practice·2023

Same author

Fecal microbiota and bile acids in IBD patients undergoing screening for colorectal cancer.

Gut microbes·2022

Same author

Evaluation by a Machine Learning System of Two Preparations for Small Bowel Capsule Endoscopy: The BUBS (Burst Unpleasant Bubbles with Simethicone) Study.

Journal of clinical medicine·2022

Search research articles

Related Experiment Video

Updated: Jun 15, 2026

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

Bacterial flora in inflammatory bowel disease.

Philippe Marteau¹

¹University Paris 7 and AP-HP, Medicosurgical Department of Digestive Diseases, Lariboisière Hospital, Paris, France. philippe.marteau@lrb.aphp.fr

Digestive Diseases (Basel, Switzerland)

|March 6, 2010

Summary

The intestinal microbiota of inflammatory bowel disease (IBD) patients is unstable and differs from healthy individuals. This imbalance, known as dysbiosis, may contribute to the development of IBD.

Area of Science:

Gastroenterology
Microbiology
Immunology

Background:

Inflammatory bowel disease (IBD) pathogenesis involves host genetics, mucosal immunity, and the intestinal environment.
Gut microbiota significantly influences mucosal structure, immune cells, and intestinal functions.
Host immune responses are modulated by microbial molecules recognized by Toll-like receptors and nucleotide oligomerisation-binding domain proteins.

Purpose of the Study:

To investigate the differences in gut microbiota composition between IBD patients and healthy controls.
To explore the potential role of microbial imbalance (dysbiosis) in IBD pathogenesis.

Main Methods:

Comparative analysis of intestinal microbiota in IBD patients and healthy individuals.
Examination of microbial composition in both intestinal lumen and mucosal samples.

More Related Videos

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4⁺ T Cells to Immunodeficient Mice

Published on: December 16, 2021

Chronic Salmonella Infection Induced Intestinal Fibrosis

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Related Experiment Videos

Last Updated: Jun 15, 2026

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach

Published on: May 2, 2018

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4⁺ T Cells to Immunodeficient Mice

Published on: December 16, 2021

Chronic Salmonella Infection Induced Intestinal Fibrosis

Chronic Salmonella Infection Induced Intestinal Fibrosis

Published on: September 22, 2019

Identification of specific bacterial species associated with IBD, including potential pro-inflammatory organisms.

Main Results:

IBD patients exhibit distinct and unstable gut microbiota compared to controls.
A decrease in the abundance and biodiversity of dominant bacteria, particularly Firmicutes (e.g., Faecalibacterium prausnitzii), is observed in IBD.
Potentially pro-inflammatory microorganisms like Mycobacterium paratuberculosis and certain Escherichia coli strains are more prevalent in IBD patients.

Conclusions:

Dysbiosis, an imbalance in the intestinal microbiota, is strongly suggested to favor the development and progression of IBD.
Specific bacterial alterations, such as reduced Firmicutes, are linked to Crohn's disease and its recurrence.